Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Capricor Therapeutics (CAPR) Shares Issued (2016 - 2025)

Capricor Therapeutics (CAPR) has 15 years of Shares Issued data on record, last reported at $6950.0 in Q3 2025.

  • For Q3 2025, Shares Issued fell 99.99% year-over-year to $6950.0; the TTM value through Sep 2025 reached $152.2 million, up 108.45%, while the annual FY2024 figure was $152.3 million, 496.98% up from the prior year.
  • Shares Issued reached $6950.0 in Q3 2025 per CAPR's latest filing, down from $19580.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $152.1 million in Q4 2024 and bottomed at -$2.2 million in Q2 2024.
  • Average Shares Issued over 5 years is $17.6 million, with a median of $2.0 million recorded in 2022.
  • The widest YoY moves for Shares Issued: up 14096.95% in 2023, down 212.57% in 2023.
  • A 5-year view of Shares Issued shows it stood at $20.2 million in 2021, then crashed by 38.52% to $12.4 million in 2022, then tumbled by 116.68% to -$2.1 million in 2023, then surged by 7452.95% to $152.1 million in 2024, then tumbled by 100.0% to $6950.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Issued were $6950.0 in Q3 2025, $19580.0 in Q2 2025, and $50354.0 in Q1 2025.